• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

贝鲁莫司地尔及其降解产物的综合色谱分析:方法开发、验证及计算机毒性评估

Comprehensive chromatographic analysis of Belumosudil and its degradation products: Development, validation, and In silico toxicity assessment.

作者信息

Ali Awadh M, Alanazi Mohammed M, Attwa Mohamed W, Darwish Ibrahim A, Darwish Hany W

机构信息

Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh, 11451, Saudi Arabia.

出版信息

Heliyon. 2024 Sep 24;10(19):e38369. doi: 10.1016/j.heliyon.2024.e38369. eCollection 2024 Oct 15.

DOI:10.1016/j.heliyon.2024.e38369
PMID:39391480
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11466582/
Abstract

Following ICH guidelines, the stability of Belumosudil, a novel protein kinase inhibitor, was tested under different stress conditions (hydrolytic, oxidative, photolytic, and thermal). A selective and efficient separation of Belumosudil and its degradation products was achieved using a Quality by Design approach. In-silico predictions using Zeneth Nexus® software were employed to assess the compound's degradation under various stress scenarios. The methodology developed through experimental design analyzed crucial process parameters connected with chromatographic systems. Reversed-phase high-performance liquid chromatography with a C18 column and a gradient mobile phase of acetonitrile and 25 mM ammonium hydrogen carbonate buffer (pH 5.6) were utilized. For structural characterization and identification of degradation products, UPLC-quadrupole tandem mass spectrometry was employed. Four distinct degradation products were identified under different stress settings. The method was thoroughly validated, assessing accuracy, selectivity, repeatability, system suitability, and linearity range (5.0-120.0 μg/mL). To predict mutagenicity and toxicity, DEREK Nexus® software was used. Two degradation products were predicted to induce skin sensitization, irritation, and hepatotoxicity in humans.

摘要

按照国际人用药品注册技术协调会(ICH)指南,对新型蛋白激酶抑制剂贝利莫司地尔在不同应激条件下(水解、氧化、光解和热解)的稳定性进行了测试。采用质量源于设计的方法实现了贝利莫司地尔及其降解产物的选择性高效分离。使用Zeneth Nexus®软件进行计算机模拟预测,以评估该化合物在各种应激情况下的降解情况。通过实验设计开发的方法分析了与色谱系统相关的关键工艺参数。采用反相高效液相色谱法,使用C18柱和乙腈与25 mM碳酸氢铵缓冲液(pH 5.6)的梯度流动相。为了对降解产物进行结构表征和鉴定,采用了超高效液相色谱-四极杆串联质谱法。在不同应激条件下鉴定出了四种不同的降解产物。该方法经过了全面验证,评估了准确性、选择性、重复性、系统适用性和线性范围(5.0 - 120.0 μg/mL)。为了预测致突变性和毒性,使用了DEREK Nexus®软件。预测有两种降解产物会在人体中引起皮肤致敏、刺激和肝毒性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/5930c28e460d/gr15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/95cc4bf6a97d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/932d3d6e3f48/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/ab742ebe5735/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/f4774a63ecaa/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/0c470c302a6b/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/2564910b1c82/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/82537a186a22/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/7ab88f58f84d/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/42f5445640c7/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/496db869b633/gr10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/7562bc775e52/gr11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/94e56ead2b80/gr12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/9b3ad3b68fd2/gr13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/54ba41828a05/gr14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/5930c28e460d/gr15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/95cc4bf6a97d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/932d3d6e3f48/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/ab742ebe5735/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/f4774a63ecaa/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/0c470c302a6b/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/2564910b1c82/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/82537a186a22/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/7ab88f58f84d/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/42f5445640c7/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/496db869b633/gr10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/7562bc775e52/gr11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/94e56ead2b80/gr12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/9b3ad3b68fd2/gr13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/54ba41828a05/gr14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928f/11466582/5930c28e460d/gr15.jpg

相似文献

1
Comprehensive chromatographic analysis of Belumosudil and its degradation products: Development, validation, and In silico toxicity assessment.贝鲁莫司地尔及其降解产物的综合色谱分析:方法开发、验证及计算机毒性评估
Heliyon. 2024 Sep 24;10(19):e38369. doi: 10.1016/j.heliyon.2024.e38369. eCollection 2024 Oct 15.
2
Selective Stability Indicating Liquid Chromatographic Method Based on Quality by Design Framework and In Silico Toxicity Assessment for Infigratinib and Its Degradation Products.基于质量源于设计框架的选择性稳定性指示液相色谱法和计算机毒性评估用于英菲格拉替尼及其降解产物。
Molecules. 2023 Nov 8;28(22):7476. doi: 10.3390/molecules28227476.
3
Forced degradation study of baricitinib and structural characterization of its degradation impurities by high-resolution mass spectrometry and nuclear magnetic resonance spectroscopy.巴瑞替尼的强制降解研究及其降解杂质的高分辨质谱和核磁共振光谱结构表征
Rapid Commun Mass Spectrom. 2023 Sep 30;37(18):e9605. doi: 10.1002/rcm.9605.
4
Identification, characterisation and in silico ADMET prediction of ozenoxacin and its degradation products using high-performance liquid chromatography-photodiode array and liquid chromatography-quadrupole time-of-flight-tandem mass spectrometry.采用高效液相色谱-光电二极管阵列和液相色谱-四极杆飞行时间串联质谱法对奥昔康唑及其降解产物进行鉴定、表征和计算机 ADMET 预测。
Rapid Commun Mass Spectrom. 2024 Feb 15;38(3):e9676. doi: 10.1002/rcm.9676.
5
Characterization of forced degradation products of ketorolac tromethamine using LC/ESI/Q/TOF/MS/MS and in silico toxicity prediction.使用液相色谱/电喷雾电离/四极杆/飞行时间串联质谱法对酮咯酸氨丁三醇的强制降解产物进行表征及计算机辅助毒性预测。
J Mass Spectrom. 2014 May;49(5):380-91. doi: 10.1002/jms.3351.
6
Characterization of forced degradation products and in silico toxicity prediction of Sofosbuvir: A novel HCV NS5B polymerase inhibitor.索磷布韦的强制降解产物表征及计算机辅助毒性预测:一种新型丙型肝炎病毒NS5B聚合酶抑制剂
J Pharm Biomed Anal. 2016 Feb 20;120:352-63. doi: 10.1016/j.jpba.2015.12.045. Epub 2015 Dec 29.
7
Development and validation of stability indicating assay method for mitapivat: Identification of novel hydrolytic, photolytic, and oxidative forced degradation products employing quadrupole-time of flight mass spectrometry.米他培南有关物质分析方法的建立与验证:采用四极杆飞行时间质谱法鉴定新的水解、光解和氧化强制降解产物。
J Sep Sci. 2024 Jul;47(14):e2400173. doi: 10.1002/jssc.202400173.
8
Isolation, Characterization, and Toxicity Study of Stress Degradation Products of Pranlukast Hydrate.普拉洛芬水合物有关物质的分离、鉴定及毒性研究。
Chem Res Toxicol. 2022 Jul 18;35(7):1206-1219. doi: 10.1021/acs.chemrestox.1c00222. Epub 2022 Jun 22.
9
Isolation and structural characterization of degradation products of afatinib dimaleate by LC-Q-TOF/MS/MS and NMR: cytotoxicity evaluation of afatinib and isolated degradation products.通过 LC-Q-TOF/MS/MS 和 NMR 对阿法替尼马来酸二甲酯的降解产物进行分离和结构表征:阿法替尼及其分离的降解产物的细胞毒性评价。
J Pharm Biomed Anal. 2019 Mar 20;166:139-146. doi: 10.1016/j.jpba.2019.01.004. Epub 2019 Jan 7.
10
LC-MS-MS Characterization of Forced Degradation Products of Fidarestat, a Novel Aldose Reductase Inhibitor: Development and Validation of a Stability-Indicating RP-HPLC Method.新型醛糖还原酶抑制剂非达司他强制降解产物的液相色谱-串联质谱表征:一种稳定性指示反相高效液相色谱法的开发与验证
J Chromatogr Sci. 2015 Oct;53(9):1588-96. doi: 10.1093/chromsci/bmv061. Epub 2015 May 25.

本文引用的文献

1
Selective Stability Indicating Liquid Chromatographic Method Based on Quality by Design Framework and In Silico Toxicity Assessment for Infigratinib and Its Degradation Products.基于质量源于设计框架的选择性稳定性指示液相色谱法和计算机毒性评估用于英菲格拉替尼及其降解产物。
Molecules. 2023 Nov 8;28(22):7476. doi: 10.3390/molecules28227476.
2
Drilling into "Quality by Design" Approach for Analytical Methods.深入探究分析方法的“质量源于设计”理念
Crit Rev Anal Chem. 2024;54(8):3478-3519. doi: 10.1080/10408347.2023.2253321. Epub 2023 Sep 4.
3
Forced degradation study of baricitinib and structural characterization of its degradation impurities by high-resolution mass spectrometry and nuclear magnetic resonance spectroscopy.
巴瑞替尼的强制降解研究及其降解杂质的高分辨质谱和核磁共振光谱结构表征
Rapid Commun Mass Spectrom. 2023 Sep 30;37(18):e9605. doi: 10.1002/rcm.9605.
4
Eco-Friendly UV-Spectrophotometric Methods Employing Magnetic Nano-Composite Polymer for the Extraction and Analysis of Sexual Boosters in Adulterated Food Products: Application of Computer-Aided Design.环保型 UV 分光光度法,采用磁性纳米复合聚合物提取和分析掺假食品中的性增强剂:计算机辅助设计的应用。
J AOAC Int. 2023 Nov 2;106(6):1608-1619. doi: 10.1093/jaoacint/qsad084.
5
A critical review of belumosudil in adult and pediatric patients with chronic graft-versus-host disease.对belumosudil用于成人和儿童慢性移植物抗宿主病患者的批判性综述。
Expert Rev Clin Immunol. 2023 Mar;19(3):241-251. doi: 10.1080/1744666X.2023.2152330. Epub 2022 Nov 30.
6
Absolute Bioavailability, Mass Balance, and Metabolic Profiling Assessment of [ C]-Belumosudil in Healthy Men: A Phase 1, Open-Label, 2-Part Study.在健康男性中评估 [C]-Belumosudil 的绝对生物利用度、物质平衡和代谢特征:一项开放标签、2 部分的 1 期研究。
Clin Pharmacol Drug Dev. 2022 Jul;11(7):786-794. doi: 10.1002/cpdd.1085. Epub 2022 Mar 1.
7
Use of Lhasa Limited Products for the In Silico Prediction of Drug Toxicity.利用拉萨有限产品进行药物毒性的计算机预测。
Methods Mol Biol. 2022;2425:435-478. doi: 10.1007/978-1-0716-1960-5_17.
8
ICH Q10 Pharmaceutical Quality System Guidance: Understanding Its Impact on Pharmaceutical Quality.ICH Q10 药物质量体系指南:理解其对药物质量的影响。
AAPS J. 2021 Nov 12;23(6):117. doi: 10.1208/s12248-021-00657-y.
9
Validated LC-MS/MS assay for quantification of the newly approved tyrosine kinase inhibitor, dacomitinib, and application to investigating its metabolic stability.经验证的 LC-MS/MS 分析测定法,用于定量新型批准的酪氨酸激酶抑制剂达可替尼,并应用于研究其代谢稳定性。
PLoS One. 2019 Apr 4;14(4):e0214598. doi: 10.1371/journal.pone.0214598. eCollection 2019.
10
Identification of reactive intermediate formation and bioactivation pathways in Abemaciclib metabolism by LC-MS/MS: metabolic investigation.通过液相色谱-串联质谱法(LC-MS/MS)鉴定阿贝西利代谢过程中的反应性中间体形成和生物活化途径:代谢研究
R Soc Open Sci. 2019 Jan 23;6(1):181714. doi: 10.1098/rsos.181714. eCollection 2019 Jan.